COMMUNIQUÉS West-GlobeNewswire

-
Orthogonal Thinker Investing to Further Product Development in Emerging Psychedelics Market Through $2.5 Million in Bridge Financing
25/09/2019 -
Ceapro to Present PGX Technology at the 3rd International Symposium on Pharmaceutical Engineering Research
25/09/2019 -
Sarepta Therapeutics to Announce 9-Month Functional Results from the SRP-9003 Gene Therapy Trial to Treat Limb-girdle Muscular Dystrophy Type 2E, or Beta-Sarcoglycanopathy
25/09/2019 -
HOOKIPA Announces Key Hires to its Executive Team
25/09/2019 -
Novelion Therapeutics Announces Completion of Aegerion Transaction and Departure of Certain Directors and Officers
25/09/2019 -
Calithera to Present at the 2019 Cantor Global Healthcare Conference
25/09/2019 -
Catalyst Pharmaceuticals to Participate in the 2019 Cantor Global Healthcare Conference
25/09/2019 -
Neos Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
25/09/2019 -
Voyager Therapeutics to Present at Upcoming Investor Conferences in October 2019
25/09/2019 -
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) Development Program at IDWeek 2019
25/09/2019 -
Intercept to Present at Upcoming Investor Conference in October
25/09/2019 -
Passage Bio to Present at Upcoming Investor Conferences
25/09/2019 -
Selecta Biosciences to Participate in Two Investor Conferences in October
25/09/2019 -
USHL Partners with headversity to Bring Digital Resilience Training to its Players
25/09/2019 -
Collegium to Participate in Upcoming Investor Conference
25/09/2019 -
Athersys to Present at 2019 Cell & Gene Meeting on the Mesa
25/09/2019 -
electroCore Provides Update on 510(k) Submission Seeking Expanded Indication for gammaCore™
25/09/2019 -
GBT Announces Participation at the 2019 Cantor Global Healthcare Conference
25/09/2019 -
TYME Launches Pivotal Stage of TYME-88-PANC Trial to Evaluate SM-88 for Third-Line Treatment of Patients with Metastatic Pancreatic Cancer
25/09/2019
Pages